Literature DB >> 4856045

Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine.

D M Tidd, A R Paterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4856045

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

Review 1.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.

Authors:  Takaya Moriyama; Rina Nishii; Virginia Perez-Andreu; Wenjian Yang; Federico Antillon Klussmann; Xujie Zhao; Ting-Nien Lin; Keito Hoshitsuki; Jacob Nersting; Kentaro Kihira; Ute Hofmann; Yoshihiro Komada; Motohiro Kato; Robert McCorkle; Lie Li; Katsuyoshi Koh; Cesar Rolando Najera; Shirley Kow-Yin Kham; Tomoya Isobe; Zhiwei Chen; Edwynn Kean-Hui Chiew; Deepa Bhojwani; Cynthia Jeffries; Yan Lu; Matthias Schwab; Hiroto Inaba; Ching-Hon Pui; Mary V Relling; Atsushi Manabe; Hiroki Hori; Kjeld Schmiegelow; Allen E J Yeoh; William E Evans; Jun J Yang
Journal:  Nat Genet       Date:  2016-02-15       Impact factor: 38.330

3.  Interference of 6-mercaptopurine riboside, 6-methylmercaptopurine riboside and azathioprine with the morphogenetic differentiation of mouse extremities in vivo and in organ culture.

Authors:  D Neubert; U Lessmöllmann; N Hinz; I Dillmann; G Fuchs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

4.  Structural basis of allele variation of human thiopurine-S-methyltransferase.

Authors:  Hong Wu; John R Horton; Kevin Battaile; Abdellah Allali-Hassani; Fernando Martin; Hong Zeng; Peter Loppnau; Masoud Vedadi; Alexey Bochkarev; Alexander N Plotnikov; Xiaodong Cheng
Journal:  Proteins       Date:  2007-04-01

5.  Molecular dynamics simulation of a human thiopurine S-methyltransferase complexed with 6-mercaptopurine model.

Authors:  Wanwimon Mokmak; Sissades Tongsima; Ekachai Jenwitheesuk
Journal:  Bioinformation       Date:  2009-09-05

6.  6-mercaptopurine: high-dose 24-h infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; J M van Baal; M B van Leeuwen; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Synchronisation by hydroxyurea does not affect the sensitivity of CEM-C7 lymphoblasts to glucocorticoids.

Authors:  F Maehira; R M Gledhill; A J Edwards; M R Norman
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

8.  Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.

Authors:  R M Gledhill; M R Norman
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

9.  MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.

Authors:  Nikki A Evensen; P Pallavi Madhusoodhan; Julia Meyer; Jason Saliba; Ashfiyah Chowdhury; David J Araten; Jacob Nersting; Teena Bhatla; Tiffaney L Vincent; David Teachey; Stephen P Hunger; Jun Yang; Kjeld Schmiegelow; William L Carroll
Journal:  Haematologica       Date:  2018-02-15       Impact factor: 9.941

10.  The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.

Authors:  H P Johnston; P Hawley; S E White; I Gibson; D M Tidd
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.